BRAIN CANCER

HER2-Positive Breast Cancer

BREAST CANCER

Bladder Cancer

Prostate Cancer

Renal Cell Carcinoma

GENITOURINARY CANCERS

Liquid Biopsies

GENOMIC TESTING

Colorectal Cancer

GASTRIC CANCER

GIST

GI CANCERS

Cervical Cancer

ENDOMETRIAL CANCER

Ovarian Cancer

GYNECOLOGIC CANCERS

HEAD & NECK CANCERS

BONE MARROW & STEM CELL TRANSPLANT

HEMATOLOGY

CAR T-CELL THERAPY

IMMUNOTHERAPY

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

LEUKEMIAS

MET-TARGETED THERAPY

SMALL CELL LUNG CANCER

BIOMARKER-DRIVEN LUNG CANCER

EGFR+ Lung Cancer

LUNG CANCER

DLBCL

Follicular Lymphoma

Mantle Cell Lymphoma

LYMPHOMAS

MPNs

MULTIPLE MYELOMA

NTRK GENE FUSIONS

SARCOMA

Melanoma

SKIN CANCERS

THYROID CANCERS

NEWS

All News

FDA Briefs

Oncology Icons

Special Reports

Voices from the Field

CONFERENCES

Conference Coverage

Conference Listing

Data Dialogue with the Oncology Brothers

MEDIA

All Videos

Case-Based Peer Perspectives

Expert Perspective Virtual Tumor Board

Interviews

Investigator Perspectives

Medical World News

Pivotal Practice Views with the Oncology Brothers

Podcasts

Precision Medicine

PUBLICATIONS

All Publications

Evolving Paradigms

Peers & Perspectives in Oncology

Targeted Therapies in Oncology

CME/CE

RESOURCES

Case-Based Roundtable Series

Clinical Trials

Partners

Precision Medicine Perspectives

Press Releases

Treatment Resources

SUBSCRIBE

eNewsletter

Print Subscription

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

About Us

Advertise

Contact Us

CureToday.com

CancerNetwork.com

OncLive.com

OncNursingNews.com

Do Not Sell My Information

Privacy

Terms & Conditions

Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Facebook

Linkedin

Twitter

YouTube

Instagram

Featured Clinical Focus

BTK Inhibitors: In-Focus

Biomarker-Driven Lung Cancer

Bone Marrow & SCT

CAR T-Cell Therapy

EGFR-Positive Lung Cancer

Endometrial Cancer

Lung Cancer

Multiple Myeloma

Small Cell Lung Cancer

Thyroid Cancers

Clinical Focus

Brain Cancer

Breast Cancer

Gastrointestinal Cancer

Genitourinary Cancers

Gynecologic Cancers

Head & Neck Cancers

Hematology

Leukemias

Lymphomas

Sarcoma

Skin Cancers

Spotlight

Case Based Peer Perspectives


Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.

1rem

Relapsed and Refractory CLL with Javier Pinilla-lbarz, MD, PhD and Paul Barr, MD

Relapsed and Refractory CLL with Javier Pinilla-lbarz, MD, PhD and Paul Barr, MD: Case 2

Videos

Javier Pinilla-Ibarz, MD, PhD: Relapse Following Purine Analog Therapy

Javier Pinilla-Ibarz, MD, PhD: Treatment Options for Patients With Previously Treated CLL

Javier Pinilla-Ibarz, MD, PhD: Bendamustine/Rituximab Therapy

Javier Pinilla-Ibarz, MD, PhD: Options to Prolong Survival

Javier Pinilla-Ibarz, MD, PhD: Phase III Data to Support Usage of Bruton's TKIs

Paul Barr, MD: Treatment Options for Patients With Previously Treated CLL

Paul Barr, MD: Bendamustine/Rituximab Therapy

Paul Barr, MD: Options to Prolong Survival

Paul Barr, MD: Relapse Following Purine Analog Therapy

Paul Barr, MD: Phase III Data to Support Usage of Bruton's TKIs